Kesheng Dai

1.7k total citations
65 papers, 1.1k citations indexed

About

Kesheng Dai is a scholar working on Hematology, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Kesheng Dai has authored 65 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Hematology, 19 papers in Molecular Biology and 15 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Kesheng Dai's work include Platelet Disorders and Treatments (34 papers), Antiplatelet Therapy and Cardiovascular Diseases (12 papers) and Blood properties and coagulation (9 papers). Kesheng Dai is often cited by papers focused on Platelet Disorders and Treatments (34 papers), Antiplatelet Therapy and Cardiovascular Diseases (12 papers) and Blood properties and coagulation (9 papers). Kesheng Dai collaborates with scholars based in China, United States and Oman. Kesheng Dai's co-authors include Lili Zhao, Suping Li, Changgeng Ruan, Rong Yan, Rong Yan, Xiaoping Du, Michael C. Berndt, Richard J. Bodnar, Zhicheng Wang and Mengxing Chen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Advanced Materials and Blood.

In The Last Decade

Kesheng Dai

60 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kesheng Dai China 21 443 364 151 147 145 65 1.1k
K. Vinod Vijayan United States 21 472 1.1× 312 0.9× 201 1.3× 157 1.1× 173 1.2× 43 1.2k
Cheng‐Hsiang Kuo Taiwan 19 289 0.7× 534 1.5× 133 0.9× 109 0.7× 270 1.9× 48 1.3k
Sebastian Vogel Germany 22 238 0.5× 397 1.1× 138 0.9× 141 1.0× 339 2.3× 40 1.2k
Joachim Pircher Germany 21 200 0.5× 421 1.2× 138 0.9× 97 0.7× 383 2.6× 41 1.2k
Volker Huck Germany 19 306 0.7× 240 0.7× 57 0.4× 84 0.6× 264 1.8× 42 1.1k
Shawn M. Jobe United States 17 432 1.0× 777 2.1× 402 2.7× 148 1.0× 170 1.2× 38 1.4k
Todd M. Getz United States 17 610 1.4× 291 0.8× 212 1.4× 102 0.7× 160 1.1× 32 1.2k
Joyce Chan United States 14 293 0.7× 730 2.0× 275 1.8× 108 0.7× 208 1.4× 21 1.5k
Imala Alwis Australia 13 326 0.7× 290 0.8× 99 0.7× 62 0.4× 151 1.0× 21 820
Gurunathan Murugesan United States 13 234 0.5× 423 1.2× 149 1.0× 105 0.7× 87 0.6× 21 954

Countries citing papers authored by Kesheng Dai

Since Specialization
Citations

This map shows the geographic impact of Kesheng Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kesheng Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kesheng Dai more than expected).

Fields of papers citing papers by Kesheng Dai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kesheng Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kesheng Dai. The network helps show where Kesheng Dai may publish in the future.

Co-authorship network of co-authors of Kesheng Dai

This figure shows the co-authorship network connecting the top 25 collaborators of Kesheng Dai. A scholar is included among the top collaborators of Kesheng Dai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kesheng Dai. Kesheng Dai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhao, Lili, Jiahao Du, Ying Hu, et al.. (2025). A novel antibody against GPIbα inhibits platelet function and thrombosis without increasing bleeding. International Journal of Biological Macromolecules. 304(Pt 1). 140739–140739. 1 indexed citations
2.
Wang, Xuexiang, Shuang Chen, Jun Wan, et al.. (2025). Iloprost Concentration‐Dependently Attenuates Platelet Function and Apoptosis by Elevating PKA Activity. Journal of Cellular and Molecular Medicine. 29(3). e70403–e70403.
3.
Shen, Jie, Jiaojiao Li, Jiahao Du, et al.. (2024). Platelet Glycoprotein Ibα Cytoplasmic Tail Exacerbates Thrombosis During Bacterial Sepsis. International Journal of Molecular Sciences. 25(21). 11548–11548. 3 indexed citations
4.
Li, Shujun, et al.. (2024). Activation of AMPK in platelets promotes the production of offspring. Platelets. 35(1). 2334701–2334701.
5.
Xia, Yue, Jun Liu, Biao Yang, et al.. (2024). Essential role of glycoprotein Ibα in platelet activation. Blood Advances. 8(13). 3388–3401. 3 indexed citations
6.
Pang, Ningbo, Yingwei Li, Chunliang Liu, et al.. (2023). Cyclic thrombocytopenia associated with estradiol: a case report. Hematology. 28(1). 2240140–2240140.
7.
Khan, Shoaib, et al.. (2023). X-rays Stimulate Granular Secretions and Activate Protein Kinase C Signaling in Human Platelets. Current Issues in Molecular Biology. 45(7). 6024–6039. 2 indexed citations
8.
Li, Shujun, et al.. (2023). Alantolactone induces platelet apoptosis by activating the Akt pathway. Platelets. 34(1). 2173505–2173505. 2 indexed citations
9.
Han, Lulu, Yang Zhao, Xingzhong Zhang, et al.. (2021). The binding of autotaxin to integrins mediates hyperhomocysteinemia-potentiated platelet activation and thrombosis in mice and humans. Blood Advances. 6(1). 46–61. 13 indexed citations
10.
Yan, Rong, Ningbo Pang, Bin Cheng, et al.. (2021). Essential role of zyxin in platelet biogenesis and glycoprotein Ib-IX surface expression. Cell Death and Disease. 12(11). 955–955. 4 indexed citations
11.
Dai, Lan, et al.. (2021). Carbamazepine Induces Platelet Apoptosis and Thrombocytopenia Through Protein Kinase A. Frontiers in Pharmacology. 12. 749930–749930. 11 indexed citations
12.
Dai, Kesheng, et al.. (2018). Effects of remote ischemic post-conditioning on platelet activation of AMI patients. Experimental and Therapeutic Medicine. 16(2). 1273–1277. 7 indexed citations
13.
Xu, Yujia, Yanan Hao, Xin Xu, et al.. (2017). A novel STAT3 inhibitor negatively modulates platelet activation and aggregation. Acta Pharmacologica Sinica. 38(5). 651–659. 20 indexed citations
14.
Zhang, Yiwen, Jian Zhang, Rong Yan, et al.. (2017). Receptor-interacting protein kinase 3 promotes platelet activation and thrombosis. Proceedings of the National Academy of Sciences. 114(11). 2964–2969. 36 indexed citations
15.
Zhang, Ping, Juan Du, Lili Zhao, et al.. (2013). The role of intraplatelet reactive oxygen species in the regulation of platelet glycoprotein Ibα ectodomain shedding. Thrombosis Research. 132(6). 696–701. 17 indexed citations
16.
Shou, Liu‐Mei, Qiongyan Zhang, Wei Li, et al.. (2013). Cantharidin and norcantharidin inhibit the ability of MCF-7 cells to adhere to platelets via protein kinase C pathway-dependent downregulation of α2 integrin. Oncology Reports. 30(3). 1059–1066. 54 indexed citations
17.
Zhang, Weilin, Lili Zhao, Jun Liu, et al.. (2012). Role of 14-3-3ζ in Platelet Glycoprotein Ibα-von Willebrand Factor Interaction-Induced Signaling. International Journal of Molecular Sciences. 13(5). 5364–5374. 6 indexed citations
18.
Zhang, Weilin, Lili Zhao, Jun Liu, et al.. (2012). Cisplatin induces platelet apoptosis through the ERK signaling pathway. Thrombosis Research. 130(1). 81–91. 43 indexed citations
19.
Li, Guoming, et al.. (2010). Crystallization and preliminary X-ray crystallographic studies of human FAIM protein. Acta Crystallographica Section F Structural Biology and Crystallization Communications. 66(8). 935–937. 1 indexed citations
20.
Dai, Kesheng, et al.. (2003). Generation and characterization of recombinant single chain Fv antibody that recognizes platelet glycoprotein Ibα. Thrombosis Research. 109(2-3). 137–144. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by K. Vinod Vijayan Breakdown of academic impact, for papers by Cheng‐Hsiang Kuo Breakdown of academic impact, for papers by Sebastian Vogel Breakdown of academic impact, for papers by Joachim Pircher Breakdown of academic impact, for papers by Volker Huck Breakdown of academic impact, for papers by Shawn M. Jobe Breakdown of academic impact, for papers by Todd M. Getz Breakdown of academic impact, for papers by Joyce Chan Breakdown of academic impact, for papers by Imala Alwis Breakdown of academic impact, for papers by Gurunathan Murugesan
Rankless by CCL
2026